Comparative Efficacy of Pre and Post-Exposure Pro-Phylaxis Using Local Rabies Vaccine by IM Route
DOI:
https://doi.org/10.69547/TSFJB.030101Keywords:
Rabies, Vaccine, Antibodies, ELISA, infectionAbstract
Rabies is an infectious but preventable disease with proper vaccination. Pre-exposure prophylaxis means using medications or vaccines against a given pathogen in people who have not yet been exposed to the given pathogen. Post-exposure prophylaxis means the use of medications in people who are exposed to a certain pathogen. This study aimed to evaluate the seroconversion of anti-rabies IgG antibodies following the administration of the Indigenous rabies vaccine. For this purpose, n=150 individuals were enrolled with 20% in the pre-exposure prophylaxis group (PrEPG) and 80% in the post-exposure prophylaxis group (PEPG). The PEPG is further categorized into 3 different sub-groups [(2-15), (15-45), (>45) years] according to their ages. Indirect ELISA was used for the detection of antibodies IgG in serum samples. Seroconversion level revealed that the local vaccine used is effective in inducing immunity in individuals with OD values ranging from 0.76-≥2.92 about positive control OD values.
References
Singh R, Singh KP, Cherian S, et al. Rabies – epidemiology, pathogenesis, public health concerns and advances in diagnosis and control: a comprehensive review. Vet Q. 2017;37(1):212-251. https://doi.org/10.1080/01652176.2017.1343516 DOI: https://doi.org/10.1080/01652176.2017.1343516
Buzayehu Barecha C, Girzaw F, Kandi V, Pal M. Epidemiology and public health significance of rabies. Published 2017. Accessed February 14, 2025. https://pimr.org.in/Barecha-new.PDF
Lanigan LG, Russell DS, Woolard KD, et al. Comparative pathology of the peripheral nervous system. Vet Pathol. 2020;58(1):10-33. https://doi.org/10.1177/0300985820959231 DOI: https://doi.org/10.1177/0300985820959231
Milton P, Priya GB, Ghatak S, Das S. Viral zoonoses: wildlife perspectives. In: Livestock Diseases and Management. Springer Nature; 2020:339-378. https://doi.org/10.1007/978-981-15-2651-0_15 DOI: https://doi.org/10.1007/978-981-15-2651-0_15
Tiwari HK, Gogoi-Tiwari J, Robertson ID. Eliminating dog-mediated rabies: challenges and strategies. Anim Dis. 2021;1(1). https://doi.org/10.1186/s44149-021-00023-7 DOI: https://doi.org/10.1186/s44149-021-00023-7
Ullah S, Ullah A, Khan T, et al. An overview of the selected zoonotic diseases in Pakistan. Int J Agric Biosci. 2023;1(Zoonosis Volume 1):237-254. https://doi.org/10.47278/book.zoon/2023.017 DOI: https://doi.org/10.47278/book.zoon/2023.017
Ditsele B. The epidemiology of rabies in domestic ruminants in Botswana [doctoral dissertation]. Murdoch University; 2016.
Shahin F, Qureshi Z, Hassan M, et al. A surveillance for probable detection of rabies virus in wild and domestic animals. Biomed Lett. 2015;1(2):59-62.
World Health Organization. WHO Expert Consultation on Rabies: First Report. World Health Organization; 2005.
Fekadu M, Shaddock JH, Baer GM. Intermittent excretion of rabies virus in the saliva of a dog two and six months after it had recovered from experimental rabies. Am J Trop Med Hyg. 1981;30(5):1113-1115. https://doi.org/10.4269/ajtmh.1981.30.1113 DOI: https://doi.org/10.4269/ajtmh.1981.30.1113
Ciconello FN, Katz ISS, Fernandes ER, Guedes F, Silva SR. A comparative review of serological assays for the detection of rabies virus-specific antibodies. Acta Trop. 2022;226:106254. https://doi.org/10.1016/j.actatropica.2021.106254 DOI: https://doi.org/10.1016/j.actatropica.2021.106254
Moore SM, Pralle S, Engelman L, Hartschuh H, Smith M. Rabies vaccine response measurement is assay dependent. Biologicals. 2016;44(6):481-486. https://doi.org/10.1016/j.biologicals.2016.09.007 DOI: https://doi.org/10.1016/j.biologicals.2016.09.007
Knobel D, Cleaveland S, Coleman P, et al. Surveillance and response, World Health Organization, Regional Office for the Western Pacific. Bull World Health Organ. 2005;83(5):360-368.
Yousaf MZ, Qasim M, Zia S, et al. Rabies molecular virology, diagnosis, prevention and treatment. Virol J. 2012;9(1). https://doi.org/10.1186/1743-422x-9-50 DOI: https://doi.org/10.1186/1743-422X-9-50
Centers for Disease Control and Prevention (CDC). Human rabies—Virginia, 2009. MMWR Morb Mortal Wkly Rep. 2010;59(38).
Parviz S, Chotani R, McCormick J, Fisher-Hoch S, Luby S. Rabies deaths in Pakistan: results of ineffective post-exposure treatment. Int J Infect Dis. 2004;8(6):346-352. https://doi.org/10.1016/j.ijid.2004.02.008 DOI: https://doi.org/10.1016/j.ijid.2004.02.008
Bernard MC, Boudet F, Pineda-Peña AC, Guinet-Morlot F. Inhibitory effect of concomitantly administered rabies immunoglobulins on the immunogenicity of commercial and candidate human rabies vaccines in hamsters. Sci Rep. 2022;12(1). https://doi.org/10.1038/s41598-022-10281-1 DOI: https://doi.org/10.1038/s41598-022-10281-1
Kavaklova L, Eskenazy M, Gancheva T, Vacheva V. Enzyme-linked immunosorbent assay for quantification of rabies antibodies in human sera. Acta Virol. 2016;28(5):422-427. https://europepmc.org/article/med/6151357
Fontana D, Rodriguez MC, Garay E, Russo S, Prieto C. Optimization and validation of a blocking ELISA for quantitation of anti-rabies immunoglobulins in multispecies sera. Appl Microbiol Biotechnol. 2020;104(9):4127-4139. https://doi.org/10.1007/s00253-020-10490-6 DOI: https://doi.org/10.1007/s00253-020-10490-6
Chabaud-Riou M, Moreno N, Guinchard F, et al. G-protein based ELISA as a potency test for rabies vaccines. Biologicals. 2017;46:124-129. https://doi.org/10.1016/j.biologicals.2017.02.002 DOI: https://doi.org/10.1016/j.biologicals.2017.02.002
Rahimi P, Vahabpour R, Aghasadeghi MR, et al. Neutralizing antibody response after intramuscular purified Vero cell rabies vaccination (PVRV) in Iranian patients with specific medical conditions. PLoS One. 2015;10(10):e0139171. https://doi.org/10.1371/journal.pone.0139171 DOI: https://doi.org/10.1371/journal.pone.0139171
Wodi AP, Hamborsky J, Morelli V, Schillie S. Epidemiology and prevention of vaccine-preventable diseases. In: Hall E, ed. US Department of Health and Human Services, Centers for Disease Control and Prevention; 2021:275-286.
World Health Organization. Oral vaccination of dogs against rabies. Food & Agriculture Organization; 2023.
Hu Q, Liu MQ, Zhu ZG, Zhu ZR, Lu S. Comparison of safety and immunogenicity of purified chick embryo cell vaccine using Zagreb and Essen regimens in patients with category II exposure in China. Hum Vaccin Immunother. 2014;10(6):1645-1649. https://doi.org/10.4161/hv.28420 DOI: https://doi.org/10.4161/hv.28420
Moulenat T, Petit C, Bosch Castells V, Houillon G. Purified Vero cell rabies vaccine (PVRV, Verorab®): a systematic review of intradermal use between 1985 and 2019. Trop Med Infect Dis. 2020;5(1):40. https://doi.org/10.3390/tropicalmed5010040 DOI: https://doi.org/10.3390/tropicalmed5010040
Kulkarni PS, Sahai A, Bhagwat Gunale, Dhere RM. Development of a new purified Vero cell rabies vaccine (Rabivax-S) at the Serum Institute of India Pvt Ltd. Expert Rev Vaccines. 2017;16(4):303-311. https://doi.org/10.1080/14760584.2017.1294068 DOI: https://doi.org/10.1080/14760584.2017.1294068
Li J, Pan R, Yue F, et al. Evaluation of the efficacy of the vaccine production process in removing residual host cell DNA from the Vero cell rabies vaccine. Vaccines (Basel). 2024;12(12):1379. https://doi.org/10.3390/vaccines12121379 DOI: https://doi.org/10.3390/vaccines12121379
Rourou S, Ben Zakkour M, Kallel H. Adaptation of Vero cells to suspension growth for rabies virus production in different serum-free media. Vaccine. 2019;37(47). https://doi.org/10.1016/j.vaccine.2019.05.092 DOI: https://doi.org/10.1016/j.vaccine.2019.05.092
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Kaneez Fatima, Shahid Nawaz, Firnas Ata Ur Rehman, Muhammd Furqan Shahid, Nadia Mukhtar, Tahir Yaqub
This work is licensed under a Creative Commons Attribution 4.0 International License.
Under the following terms:
- Attribution - You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions - You may not apply legal terms ortechnological measures that legally restrict others from doing anything the license permits.
